These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7768562)

  • 61. Brain expression of VEGF and its receptors in SHR-SP and effects of an endothelin blocker.
    Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S160-4. PubMed ID: 15838270
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
    Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
    Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension.
    Fink GD; Johnson RJ; Galligan JJ
    Hypertension; 2000 Jan; 35(1 Pt 2):464-9. PubMed ID: 10642342
    [TBL] [Abstract][Full Text] [Related]  

  • 66. State-of-the-Art lecture. Role of endothelin-1 in hypertension.
    Schiffrin EL
    Hypertension; 1999 Oct; 34(4 Pt 2):876-81. PubMed ID: 10523377
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.
    Nishikawa K; Inada Y; Shibouta Y; Wada T; Ojima M; Kubo K; Naka T
    Blood Press Suppl; 1994; 5():7-14. PubMed ID: 7889205
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
    Ammarguellat F; Larouche I; Schiffrin EL
    Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner.
    Trenkner J; Priem F; Bauer C; Neumayer HH; Raschak M; Hocher B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():385S-388S. PubMed ID: 12193128
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The lipoxygenase inhibitor phenidone is a potent hypotensive agent in the spontaneously hypertensive rat.
    Stern N; Nozawa K; Golub M; Eggena P; Knoll E; Tuck ML
    Am J Hypertens; 1993 Jan; 6(1):52-8. PubMed ID: 8427662
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
    Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Local administration of ETA (but not ETB) blockers into the PAG area of the brain decreases blood pressure of DOCA-salt rats.
    Di Filippo C; D'Amico M; Piegari E; Rinaldi B; Filippelli A; Rossi F
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):123-6. PubMed ID: 12122498
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive rats.
    Lee JY; Warner RB; Brune ME; Adler AL; Winn M; De B; Zydowsky TM; Opgenorth TJ; Kerkman DJ; DeBernardis JF
    Am J Hypertens; 1994 Nov; 7(11):975-83. PubMed ID: 7848624
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K; Zhang X; Dunham EW; Zimmerman BG
    Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Models of cardiovascular disease: measurement of antihypertensive activity in the conscious rat (SHR, DOCA-salt, and Goldblatt hypertension models).
    Guillaume P; Provost D; Legrand P; Godes M; Lacroix P
    Curr Protoc Pharmacol; 2009 Mar; Chapter 5():Unit 5.53. PubMed ID: 22294399
    [TBL] [Abstract][Full Text] [Related]  

  • 77. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
    Li L; Watts SW; Banes AK; Galligan JJ; Fink GD; Chen AF
    Hypertension; 2003 Sep; 42(3):316-21. PubMed ID: 12885792
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of ETB receptors in normotensive and hypertensive rats as revealed by the non-peptide selective ETB receptor antagonist Ro 46-8443.
    Clozel M; Breu V
    FEBS Lett; 1996 Mar; 383(1-2):42-5. PubMed ID: 8612787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chung TH; Lin SZ; Chang NC
    J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.